BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8708981)

  • 1. Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats.
    Megwa SA; Benson HA; Roberts MS
    J Pharm Pharmacol; 1995 Nov; 47(11):891-6. PubMed ID: 8708981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies.
    Cross SE; Anderson C; Roberts MS
    Br J Clin Pharmacol; 1998 Jul; 46(1):29-35. PubMed ID: 9690946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Capryloyl Salicylic Acid, Hexyldodecyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Ethylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, TEA-Salicylate, and Tridecyl Salicylate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2003; 22 Suppl 3():1-108. PubMed ID: 14617432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self promotion of deep tissue penetration and distribution of methylsalicylate after topical application.
    Cross SE; Megwa SA; Benson HA; Roberts MS
    Pharm Res; 1999 Mar; 16(3):427-33. PubMed ID: 10213375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application.
    Singh P; Roberts MS
    J Pharmacokinet Biopharm; 1993 Aug; 21(4):337-73. PubMed ID: 8133461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of salicylic acid following topically applied salicylate derivatives.
    Morra P; Bartle WR; Walker SE; Lee SN; Bowles SK; Reeves RA
    Ann Pharmacother; 1996 Sep; 30(9):935-40. PubMed ID: 8876850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of trolamine salicylate into the skeletal muscle of the pig.
    Baldwin JR; Carrano RA; Imondi AR
    J Pharm Sci; 1984 Jul; 73(7):1002-4. PubMed ID: 6470939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative tissue absorption of oral 14C-aspirin and topical triethanolamine 14C-salicylate in human and canine knee joints.
    Rabinowitz JL; Feldman ES; Weinberger A; Schumacher HR
    J Clin Pharmacol; 1982 Jan; 22(1):42-8. PubMed ID: 6977559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo skin penetration of salicylic compounds in hairless rats.
    Simonsen L; Petersen MB; Groth L
    Eur J Pharm Sci; 2002 Oct; 17(1-2):95-104. PubMed ID: 12356424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ion pairing with alkylamines on the in-vitro dermal penetration and local tissue disposition of salicylates.
    Megwa SA; Cross SE; Whitehouse MW; Benson HA; Roberts MS
    J Pharm Pharmacol; 2000 Aug; 52(8):929-40. PubMed ID: 11007063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H
    Liang X; Chen YL; Jiang XJ; Wang SM; Zhang JW; Gui SY
    Eur J Pharm Sci; 2017 Mar; 100():155-162. PubMed ID: 28063969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiated in vivo skin penetration of salicylic compounds in hairless rats measured by cutaneous microdialysis.
    Simonsen L; Jørgensen A; Benfeldt E; Groth L
    Eur J Pharm Sci; 2004 Feb; 21(2-3):379-88. PubMed ID: 14757512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application.
    Singh P; Roberts MS
    J Pharmacol Exp Ther; 1994 Jan; 268(1):144-51. PubMed ID: 8301551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin.
    Higaki K; Nakayama K; Suyama T; Amnuaikit C; Ogawara K; Kimura T
    Int J Pharm; 2005 Jan; 288(2):227-33. PubMed ID: 15620862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of phonophoresis on serum salicylate levels.
    Oziomek RS; Perrin DH; Herold DA; Denegar CR
    Med Sci Sports Exerc; 1991 Apr; 23(4):397-401. PubMed ID: 2056895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential dangers from topical preparations containing methyl salicylate.
    Chan TY
    Hum Exp Toxicol; 1996 Sep; 15(9):747-50. PubMed ID: 8880210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous penetration of octyl salicylate from representative sunscreen formulations through human skin in vitro.
    Walters KA; Brain KR; Howes D; James VJ; Kraus AL; Teetsel NM; Toulon M; Watkinson AC; Gettings SD
    Food Chem Toxicol; 1997 Dec; 35(12):1219-25. PubMed ID: 9449227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of l-menthol and dl-camphor on the penetration and hydrolysis of methyl salicylate in hairless mouse skin.
    Yano T; Kanetake T; Saita M; Noda K
    J Pharmacobiodyn; 1991 Dec; 14(12):663-9. PubMed ID: 1812275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iontophoretic transdermal delivery of salicylic acid and lidocaine to local subcutaneous structures.
    Singh P; Roberts MS
    J Pharm Sci; 1993 Feb; 82(2):127-31. PubMed ID: 8445523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion modelling of percutaneous absorption kinetics. Predicting urinary excretion from in vitro skin permeation tests (IVPT) for an infinite dose.
    Liu X; Yousef S; Anissimov YG; van der Hoek J; Tsakalozou E; Ni Z; Grice JE; Roberts MS
    Eur J Pharm Biopharm; 2020 Apr; 149():30-44. PubMed ID: 32018051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.